MedTrace Logo

Auricular Acupuncture for Post-Stroke Constipation

NCT07751224 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-08-07

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if auricular acupuncture can improve constipation in hospitalized patients with post-stroke constipation. It will also evaluate whether auricular acupuncture is safe when used together with standard care.

The main questions it aims to answer are:

* Does auricular acupuncture reduce constipation severity in patients with post-stroke constipation?
* Does auricular acupuncture intestinal symptoms compared with sham auricular acupuncture?
* Is auricular acupuncture safe for patients with post-stroke constipation? Researchers will compare auricular acupuncture plus standard care with sham auricular acupuncture plus standard care to determine whether auricular acupuncture provides additional benefits in relieving constipation symptoms.

Participants will:

* Be randomly assigned to receive either auricular acupuncture or sham auricular acupuncture
* Receive one treatment session daily for 8 consecutive treatment days in addition to standard care.
* Complete assessment of constipation severity and intestinal symptoms before and during the study.
* Be monitored for any adverse events throughout the study.

Conditions

Interventions

PROCEDURE

Auricular Acupuncture

Auricular acupuncture was performed at six therapeutic auricular acupoints (AH6a, HX2, TF3, CO7, CO17, and CO14) on the left ear. Needles were manually stimulated for 30 seconds every 5 minutes during each 20-minute treatment session. Treatment was administered once daily, five sessions per week, for eight treatment days.

PROCEDURE

Sham Auricular Acupuncture

Sham auricular acupuncture was performed at six non-therapeutic auricular points (SF1, SF2, SF3, AH1, AH2, and AH3) using the same needle manipulation, treatment duration, and treatment schedule as the experimental intervention.

Sponsors & Collaborators

  • University of Medicine and Pharmacy at Ho Chi Minh City

    collaborator OTHER

  • Ho Chi Minh City Orthopedics and Rehabilitation Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-01
Primary Completion
2025-06-01
Completion
2025-07-01

Countries

  • Vietnam

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07751224 on ClinicalTrials.gov